µ-Conotoxin KIIIA (TFA)
CAT:
804-HY-P5141A-02
Size:
10 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

µ-Conotoxin KIIIA (TFA)
- UNSPSC Description: μ-Conotoxin KIIIA TFA is an analgesic μ-conotoxin that can be isolated from Conus kinoshitai. μ-Conotoxin KIIIA blocks mammalian neuronal voltage-gated sodium channels (VGSCs) (Nav1.2). μ-Conotoxin KIIIA TFA can be used for research of pain[1][2].
- Target Antigen: Sodium Channel
- Type: Peptides
- Related Pathways: Membrane Transporter/Ion Channel
- Applications: COVID-19-immunoregulation
- Field of Research: Inflammation/Immunology
- Purity: 99.20
- Solubility: H2O : 100 mg/mL (ultrasonic)
- Smiles: O=C([C@@H](N)CSSC[C@H](NC1=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H]2CCCNC(N)=N)=O)CO)=O)CC3=CNC=N3)=O)CC(O)=O)=O)CCCNC(N)=N)=O)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H]1CC4=CNC5=CC=CC=C45)=O)CCCCN)=O)CO)=O)CO)=O)CSSC[C@H](NC6=O)C(N)=O)=O)CC(N)=O)=O)CSSC[C@@H]6NC2=O.O=C(O)C(F)(F)F.[x]
- Molecular Weight: 1884.16 (free base)
- References & Citations: [1]Khoo KK,et al. Structure of the analgesic mu-conotoxin KIIIA and effects on the structure and function of disulfide deletion. Biochemistry. 2009 Feb 17;48(6):1210-9.|[2]Pan X, Li Z, et al. Molecular basis for pore blockade of human Na+ channel Nav1.2 by the μ-conotoxin KIIIA. Science. 2019 Mar 22;363(6433):1309-1313.
- Shipping Conditions: Blue Ice
- Storage Conditions: -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
- Clinical Information: No Development Reported